Hmd Biomedical Inc.
HMD Biomedical Inc., a leading name in the biomedical industry, is headquartered in Taiwan (TW) and operates extensively across Asia and beyond. Founded in 2002, the company has established itself as a pioneer in the development of innovative medical devices and diagnostic solutions, focusing on enhancing patient care and clinical efficiency. HMD Biomedical's core offerings include advanced point-of-care testing systems and high-quality laboratory equipment, distinguished by their precision and user-friendly design. The company has achieved significant milestones, including numerous certifications and partnerships that underscore its commitment to quality and innovation. With a strong market position, HMD Biomedical continues to drive advancements in healthcare technology, making a notable impact in the medical field.
DitchCarbon Score
How does Hmd Biomedical Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Machinery and Equipment industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Hmd Biomedical Inc.'s score of 18 is lower than 69% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Hmd Biomedical Inc.'s reported carbon emissions
In 2021, Hmd Biomedical Inc. reported significant carbon emissions totalling approximately 162,000,000 kg CO2e for Scope 1 and about 192,000,000 kg CO2e for Scope 2. This data reflects the company's direct and indirect emissions from its operations, with no reported Scope 3 emissions. Currently, Hmd Biomedical Inc. has not established any specific reduction targets or initiatives, nor does it participate in recognised climate pledges such as the Science Based Targets initiative (SBTi). The absence of reduction commitments indicates a potential area for improvement in their climate strategy. As a company headquartered in Taiwan (TW), Hmd Biomedical Inc. operates within an industry context that increasingly prioritises sustainability and carbon footprint reduction. However, without clear targets or commitments, the company may face challenges in aligning with global climate goals.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2021 | |
|---|---|
| Scope 1 | 162,000,000 |
| Scope 2 | 192,000,000 |
| Scope 3 | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Hmd Biomedical Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
